Literature DB >> 16801645

Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study.

H M M Smeding1, J D Speelman, M Koning-Haanstra, P R Schuurman, P Nijssen, T van Laar, B Schmand.   

Abstract

OBJECTIVE: To evaluate the cognitive and behavioral effects of bilateral subthalamic nucleus (STN) stimulation in patients with Parkinson disease (PD).
METHODS: The authors included 103 patients; 99 patients were evaluated 6 months after surgery. A control group of 39 patients with PD was formed and 36 patients were evaluated 6 months later. At baseline and at follow-up we administered neuropsychological tests of language, memory, visuospatial function, mental speed, and executive functions. A depression rating scale, a quality of life scale, self and proxy ratings of memory and dysexecutive symptoms, and a neuropsychiatric interview were also administered.
RESULTS: Six months after surgery, the STN group showed a larger decline than the control group on measures of verbal fluency, color naming, selective attention, and verbal memory. Moreover, the STN group showed a decrease in positive affect, and an increase in emotional lability and cognitive complaints. On the other hand, the STN group showed an increase in quality of life and a slight decrease in depressive symptoms. Nine percent of the STN patients had psychiatric complications (vs 3% of controls).
CONCLUSIONS: Bilateral subthalamic nucleus stimulation has an adverse effect on executive functions with implications for daily life of the patients and their relatives.

Entities:  

Mesh:

Year:  2006        PMID: 16801645     DOI: 10.1212/01.wnl.0000234881.77830.66

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  61 in total

Review 1.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?

Authors:  Rupam Borgohain; Rukmini Mridula Kandadai; Afshan Jabeen; Meena A Kannikannan
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

3.  Deep brain stimulation in Parkinson's disease.

Authors:  S J Groiss; L Wojtecki; M Südmeyer; A Schnitzler
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

4.  Does chronic subthalamic nucleus stimulation in advanced Parkinson's disease cause invalidating cognitive and behavioural dysfunctions?

Authors:  J D Speelman; H M M Smeding; B Schmand
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03       Impact factor: 10.154

5.  The Influence of Bilateral Subthalamic Nucleus Deep Brain Stimulation on Impulsivity and Prepulse Inhibition in Parkinson's Disease Patients.

Authors:  Lucy Gee; Heather Smith; Priscilla De La Cruz; Joannalee Campbell; Chris Fama; Jessica Haller; Adolfo Ramirez-Zamora; Jennifer Durphy; Era Hanspal; Eric Molho; Anne Barba; Damian Shin; Julie G Pilitsis
Journal:  Stereotact Funct Neurosurg       Date:  2015-06-10       Impact factor: 1.875

Review 6.  The effect of STN DBS on modulating brain oscillations: consequences for motor and cognitive behavior.

Authors:  Fabian J David; Miranda J Munoz; Daniel M Corcos
Journal:  Exp Brain Res       Date:  2020-06-03       Impact factor: 1.972

7.  Functional anatomy of subthalamic nucleus stimulation in Parkinson disease.

Authors:  Sarah A Eisenstein; Jonathan M Koller; Kathleen D Black; Meghan C Campbell; Heather M Lugar; Mwiza Ushe; Samer D Tabbal; Morvarid Karimi; Tamara Hershey; Joel S Perlmutter; Kevin J Black
Journal:  Ann Neurol       Date:  2014-07-02       Impact factor: 10.422

Review 8.  Current Practice and the Future of Deep Brain Stimulation Therapy in Parkinson's Disease.

Authors:  Leonardo Almeida; Wissam Deeb; Chauncey Spears; Enrico Opri; Rene Molina; Daniel Martinez-Ramirez; Aysegul Gunduz; Christopher W Hess; Michael S Okun
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

Review 9.  Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.

Authors:  Sean S O'Sullivan; Andrew H Evans; Andrew J Lees
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

10.  Cognitive declines one year after unilateral deep brain stimulation surgery in Parkinson's disease: a controlled study using reliable change.

Authors:  Laura B Zahodne; Michael S Okun; Kelly D Foote; Hubert H Fernandez; Ramon L Rodriguez; Lindsey Kirsch-Darrow; Dawn Bowers
Journal:  Clin Neuropsychol       Date:  2008-09-23       Impact factor: 3.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.